Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Frutarom Reports Second Quarter Results
Company reports sales of US$ 72.3 million, growth of 7.9%, compared with the same quarter of 2005, with gross profit of US$ 26.3 million compared with US$ 26.9 million, a decline of 2.4%.
- Frutarom Reports Second Quarter Results
Company reports sales of US$ 72.3 million, growth of 7.9%, compared with the same quarter of 2005, with gross profit of US$ 26.3 million compared with US$ 26.9 million, a decline of 2.4%.
- Lifeline Therapeutics, Inc. Announces Q4 and FY 2006 Financial and Operating Results
Company reports Q4 revenues of 1.1 million and a loss of $(1.6) million, or $(0.07) per share, compared to revenues of $2.3 million and a loss of $(2.8) million, or $(0.16) per share prior year.
- Lifeline Therapeutics, Inc. Announces Q4 and FY 2006 Financial and Operating Results
Company reports Q4 revenues of 1.1 million and a loss of $(1.6) million, or $(0.07) per share, compared to revenues of $2.3 million and a loss of $(2.8) million, or $(0.16) per share prior year.
- Corazonas Foods Spins Out From Brand New Brands
Company has "spun out" from Brand New Brands, Inc. and announced that Charles A. Lynch is chair of the board of Corazonas Foods, with Edward Marra joining Corazonas Foods' board of directors.
- Corazonas Foods Spins Out From Brand New Brands
Company has "spun out" from Brand New Brands, Inc. and announced that Charles A. Lynch is chair of the board of Corazonas Foods, with Edward Marra joining Corazonas Foods' board of directors.
- Corazonas Foods Spins Out From Brand New Brands
Company has "spun out" from Brand New Brands, Inc. and announced that Charles A. Lynch is chair of the board of Corazonas Foods, with Edward Marra joining Corazonas Foods' board of directors.
- Corazonas Foods Spins Out From Brand New Brands
Company has "spun out" from Brand New Brands, Inc. and announced that Charles A. Lynch is chair of the board of Corazonas Foods, with Edward Marra joining Corazonas Foods' board of directors.
- Coleman Natural Foods, LLC, New Powerhouse Natural and Organic Food Company Formed by Merger
Coleman Natural Foods, LLC, has been formed by merger of BC Natural Foods, LLC, located in Golden, Colorado, with KDSB Holdings, LLC, headquartered in Gainesville, Georgia.
- Coleman Natural Foods, LLC, New Powerhouse Natural and Organic Food Company Formed by Merger
Coleman Natural Foods, LLC, has been formed by merger of BC Natural Foods, LLC, located in Golden, Colorado, with KDSB Holdings, LLC, headquartered in Gainesville, Georgia.
- Coleman Natural Foods, LLC, New Powerhouse Natural and Organic Food Company Formed by Merger
Coleman Natural Foods, LLC, has been formed by merger of BC Natural Foods, LLC, located in Golden, Colorado, with KDSB Holdings, LLC, headquartered in Gainesville, Georgia.
- Coleman Natural Foods, LLC, New Powerhouse Natural and Organic Food Company Formed by Merger
Coleman Natural Foods, LLC, has been formed by merger of BC Natural Foods, LLC, located in Golden, Colorado, with KDSB Holdings, LLC, headquartered in Gainesville, Georgia.
- Advitech Announces Its Second-Quarter Results For 2006
Company reports net loss of $358,894, or $0.01 per share, compared to a net loss of $536,168, or $0.01 per share, for the same period in 2005, on sales $9,039 compared to $226,321 in 2005.
- Advitech Announces Its Second-Quarter Results For 2006
Company reports net loss of $358,894, or $0.01 per share, compared to a net loss of $536,168, or $0.01 per share, for the same period in 2005, on sales $9,039 compared to $226,321 in 2005.
- Advitech Announces Its Second-Quarter Results For 2006
Company reports net loss of $358,894, or $0.01 per share, compared to a net loss of $536,168, or $0.01 per share, for the same period in 2005, on sales $9,039 compared to $226,321 in 2005.
- Boehringer Ingelheim and IdeaSphere Announce Acquisition Deal
Boehringer Ingelheim and IdeaSphere Inc. have announced the sale of Boehringer Ingelheim's Natural Healthcare company and business Pharmaton SA (Lugano) to IdeaSphere
- Boehringer Ingelheim and IdeaSphere Announce Acquisition Deal
Boehringer Ingelheim and IdeaSphere Inc. have announced the sale of Boehringer Ingelheim's Natural Healthcare company and business Pharmaton SA (Lugano) to IdeaSphere
- Burcon granted U.S. patent
Company has been granted United States Patent Number 7,087,720; "Enhanced Oilseed Protein Recovery" for a novel and commercially important component of its protein extraction and purification
technology.
- Burcon granted U.S. patent
Company has been granted United States Patent Number 7,087,720; "Enhanced Oilseed Protein Recovery" for a novel and commercially important component of its protein extraction and purification
technology.
- Burcon granted U.S. patent
Company has been granted United States Patent Number 7,087,720; "Enhanced Oilseed Protein Recovery" for a novel and commercially important component of its protein extraction and purification
technology.
- GeoPharma Appoints Nutraceutical President
Company has appointed Robert A. Herrmann, President of its nutraceutical manufacturing division Innovative Health Products, Inc.
- GeoPharma Appoints Nutraceutical President
Company has appointed Robert A. Herrmann, President of its nutraceutical manufacturing division Innovative Health Products, Inc.
- GeoPharma Appoints Nutraceutical President
Company has appointed Robert A. Herrmann, President of its nutraceutical manufacturing division Innovative Health Products, Inc.
- GeoPharma Appoints Nutraceutical President
Company has appointed Robert A. Herrmann, President of its nutraceutical manufacturing division Innovative Health Products, Inc.
- Compound Solutions Announces CoQ10 Agreement with Premier Manufacturer in China
Company announces its agreement to represent Hangzhou Zhongmeihuadong Pharmaceutical (HZH) in CoQ10 distribution across North America and Europe.
- Compound Solutions Announces CoQ10 Agreement with Premier Manufacturer in China
Company announces its agreement to represent Hangzhou Zhongmeihuadong Pharmaceutical (HZH) in CoQ10 distribution across North America and Europe.
- Reliv International Names Michael D. Smith to Board of Directors
Company has named Michael D. Smith, former vice president of government and industry affairs at Nu Skin Enterprises, to its board of directors.
- Reliv International Names Michael D. Smith to Board of Directors
Company has named Michael D. Smith, former vice president of government and industry affairs at Nu Skin Enterprises, to its board of directors.
- Reliv International Names Michael D. Smith to Board of Directors
Company has named Michael D. Smith, former vice president of government and industry affairs at Nu Skin Enterprises, to its board of directors.
- Reliv International Names Michael D. Smith to Board of Directors
Company has named Michael D. Smith, former vice president of government and industry affairs at Nu Skin Enterprises, to its board of directors.
- United Natural Foods Reports Sales and Earnings for the Fourth Quarter and Fiscal Year
Company reports net income of $12.7 million for the fourth quarter of fiscal 2006, ended July 29, 2006, or $0.30 per share on a diluted basis, compared to $11.8 million, or $0.28 per diluted share prior year, with net sales of $619.8 million, an increase of $76.8 million, or 14.1%, from the $543.0 million recorded in the fourth quarter of fiscal 2005.
- United Natural Foods Reports Sales and Earnings for the Fourth Quarter and Fiscal Year
Company reports net income of $12.7 million for the fourth quarter of fiscal 2006, ended July 29, 2006, or $0.30 per share on a diluted basis, compared to $11.8 million, or $0.28 per diluted share prior year, with net sales of $619.8 million, an increase of $76.8 million, or 14.1%, from the $543.0 million recorded in the fourth quarter of fiscal 2005.
- Fytokem announces record second quarter financial results
Company reports net income of about $43,000 on record quarterly sales of $339,762.
- Fytokem announces record second quarter financial results
Company reports net income of about $43,000 on record quarterly sales of $339,762.
- Fytokem announces record second quarter financial results
Company reports net income of about $43,000 on record quarterly sales of $339,762.
- The Hain Celestial Group Announces Record Fourth Quarter and Fiscal Year 2006 Results
Company reports fourth quarter net sales of $195 million, a 29% increase compared with $151 million in the prior year period, GAAP net income for the fourth quarter, including special charges of $0.02 per share, was $0.22 per share compared to ($0.07) per share in the prior year quarter.
- The Hain Celestial Group Announces Record Fourth Quarter and Fiscal Year 2006 Results
Company reports fourth quarter net sales of $195 million, a 29% increase compared with $151 million in the prior year period, GAAP net income for the fourth quarter, including special charges of $0.02 per share, was $0.22 per share compared to ($0.07) per share in the prior year quarter.
- Glanbia Makes Major US Nutritionals Acquisition
Company announced the acquisition of a California based nutritional business, Seltzer Companies, Inc. US$105 million (Euro81.8 million), of which US$80.0 million
(Euro62.3 million) cash is payable on completion and US$25.0 million (Euro19.5 million) deferred payments.
- Glanbia Makes Major US Nutritionals Acquisition
Company announced the acquisition of a California based nutritional business, Seltzer Companies, Inc. US$105 million (Euro81.8 million), of which US$80.0 million
(Euro62.3 million) cash is payable on completion and US$25.0 million (Euro19.5 million) deferred payments.
- Mineral Resources International Announces Termination of Exclusive Supply Agreement with Trace Minerals Research
Company announces that its exclusive supply agreement for the U.S. health food store market with distributor Trace Minerals Research (TMR) has ended.
- Mineral Resources International Announces Termination of Exclusive Supply Agreement with Trace Minerals Research
Company announces that its exclusive supply agreement for the U.S. health food store market with distributor Trace Minerals Research (TMR) has ended.
- Martek Announces Third Quarter Financial Results
Company reports revenues of $70.4 million were achieved, compared to $39.5 million for the third quarter of fiscal 05 , with net income of $5.3 million, or $0.16 per diluted share, compared to net loss of $100,000, or $0.00 per diluted share, for the 3rd Qtr 05.
- Martek Announces Third Quarter Financial Results
Company reports revenues of $70.4 million were achieved, compared to $39.5 million for the third quarter of fiscal 05 , with net income of $5.3 million, or $0.16 per diluted share, compared to net loss of $100,000, or $0.00 per diluted share, for the 3rd Qtr 05.
- Jamieson Laboratories Centralizes Manufacturing with Closure of Vancouver Facility
Company is closing Vancouver plant in order to centralize manufacturing operations at state-of-the-art facilities at
headquarters in Windsor, Ontario.
- Jamieson Laboratories Centralizes Manufacturing with Closure of Vancouver Facility
Company is closing Vancouver plant in order to centralize manufacturing operations at state-of-the-art facilities at
headquarters in Windsor, Ontario.
- Jamieson Laboratories Centralizes Manufacturing with Closure of Vancouver Facility
Company is closing Vancouver plant in order to centralize manufacturing operations at state-of-the-art facilities at
headquarters in Windsor, Ontario.
- Trace Minerals Research Partners with Salt Lake Minerals
Company has negotiated an exclusive agreement with Salt Lake Minerals, a mineral and trace mineral extraction facility located on Utah's Great Salt Lake.
- Trace Minerals Research Partners with Salt Lake Minerals
Company has negotiated an exclusive agreement with Salt Lake Minerals, a mineral and trace mineral extraction facility located on Utah's Great Salt Lake.
- SunOpta Quadruples Acai Business
Company has provided an update on its North American Acai business, expecting to quadruple its sales of Acai in North America to approximately $4.0 million over the next 12 months.
- SunOpta Quadruples Acai Business
Company has provided an update on its North American Acai business, expecting to quadruple its sales of Acai in North America to approximately $4.0 million over the next 12 months.
- SunOpta Quadruples Acai Business
Company has provided an update on its North American Acai business, expecting to quadruple its sales of Acai in North America to approximately $4.0 million over the next 12 months.
- Chrysantis Granted Zeaxanthin Esters Patent
The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters.
- Chrysantis Granted Zeaxanthin Esters Patent
The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters.
- Chrysantis Granted Zeaxanthin Esters Patent
The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters.
- EuroPharma Signs Exclusive Agreement With New Chapter to Distribute Vectomega® Into Health Food/Natural Product Retail Channel
EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega® for the health food/natural product retail channel.
- EuroPharma Signs Exclusive Agreement With New Chapter to Distribute Vectomega® Into Health Food/Natural Product Retail Channel
EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega® for the health food/natural product retail channel.
- EuroPharma Signs Exclusive Agreement With New Chapter to Distribute Vectomega® Into Health Food/Natural Product Retail Channel
EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega® for the health food/natural product retail channel.
- EuroPharma Signs Exclusive Agreement With New Chapter to Distribute Vectomega® Into Health Food/Natural Product Retail Channel
EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega® for the health food/natural product retail channel.
- EuroPharma Signs Exclusive Agreement With New Chapter to Distribute Vectomega® Into Health Food/Natural Product Retail Channel
EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega® for the health food/natural product retail channel.
- Atrium acquires Douglas Laboratories Canada
Company announces the acquisition, effective today, of the assets of London, Ontario based Douglas Laboratories Canada, with current annual revenues of approximately $5 million.
- Atrium acquires Douglas Laboratories Canada
Company announces the acquisition, effective today, of the assets of London, Ontario based Douglas Laboratories Canada, with current annual revenues of approximately $5 million.
- Atrium acquires Douglas Laboratories Canada
Company announces the acquisition, effective today, of the assets of London, Ontario based Douglas Laboratories Canada, with current annual revenues of approximately $5 million.
- Nutrition 21 Reports Fiscal Fourth-Quarter and Full-Year 2006 Results
Company reports Q4 revenues of $2.5 million, compared to $1.9 million for the comparable period a year ago, with a net loss of $3.7 million or $(0.09) loss per diluted share compared to a $3.7 million or $(0.10) loss per diluted share in the 2005 period.
- Nutrition 21 Reports Fiscal Fourth-Quarter and Full-Year 2006 Results
Company reports Q4 revenues of $2.5 million, compared to $1.9 million for the comparable period a year ago, with a net loss of $3.7 million or $(0.09) loss per diluted share compared to a $3.7 million or $(0.10) loss per diluted share in the 2005 period.
- SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders
- SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders
- SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders
- Carrington and Swanson Health Sign Supply and Licensing Agreements for Manapol(R) Powder
Carrington Laboratories, Inc. has announced today it has entered into a two-year, non- exclusive supply agreement for Manapol(R) powder and a licensing agreement for the Manapol(R) trademark and logo with Swanson Health Products(TM).
- Carrington and Swanson Health Sign Supply and Licensing Agreements for Manapol(R) Powder
Carrington Laboratories, Inc. has announced today it has entered into a two-year, non- exclusive supply agreement for Manapol(R) powder and a licensing agreement for the Manapol(R) trademark and logo with Swanson Health Products(TM).
- Natural Alternatives International, Inc. Announces Fourth Quarter Results
Company reports net income of $1.2 million or $0.16 per diluted share on revenues of $34.2 million for Q4, compared to $285,000 or $0.04 per diluted share on revenues of $24.7 million for the comparable quarter last year.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Vitiva Slovenia reports strong sales in the first half of the year, with a record of 225% growth in comparison with the same period last year.
The leap in sales and is attributed to implementation of Vitiva's rapid-growth strategy of combining organic growth in core activities and expertise in the company's main business sectors as well as in strategic geographic regions.
Vitiva annual forecast targets 50 percent growth through broad-based segments and locations. Most sales activity is focused on traditional markets for rosemary extract products as well as a wide range of new applications requiring the company's odorless rosemary extract. For these applications, Vitiva developed the new line, INOLENS™, which eliminates the bitterness in a deodorized grade of rosemary extract.
“We're continuing to propel Vitiva’s business with breakthrough innovations and excellent in-market execution,” says Ohad Cohen, CEO of Vitiva. “This is combined with tremendous progress in plant investments and cost reduction. Large investments are also being made in applications and in the development of specific solutions for a completely new range of applications — ones that previously lacked rosemary extract.”
Vitiva’s significant growth is also the result of several strategic moves, including the initiatiion of a joint operation with leading pharmaceutical companies and in the establishment of a new sales network in Europe and North America. This move promotes Vitiva’s product lines in both traditional and new markets.
Based on the company’s strong first-half performance, Vitiva CEO expresses confidence the company will exceed its growth target for 2006 and meet goals for 2007.
Vitiva is a dynamic, fast-growing nutraceuticals company offering natural extracts with antioxidation properties and a full range of deodorized rosemary extracts in a variety of concentrations for specific applications. These pure extracts are soluble in oil or water, and are available in powder and liquid forms.
For more information please contact:
Mr. Ohad Cohen, CEO
Tel: +386217888738
E-mail: service@vitiva.si
www.vitiva.si |